SCHEMBL13775286

SCHEMBL13775286

Cc1ccc(N(c2ccc(C)c(C)c2)c2cc3c4ccc(-c5ccc6ccccc6c5)cc4c(N(c4ccc(C)c(C)c4)c4ccc(C)c(C)c4)cc3c3ccccc23)cc1C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
ALOX5 P09917 1/20 0.33
CYP1A2 P05177 5/20 0.32
ALDH1A1 P00352 4/20 0.32
RAC1 P63000 2/20 0.32
MAPT P10636 2/20 0.32
LCK P06239 1/20 0.32
FYN P06241 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ACHE P22303 1/20 0.32
SLC6A2 P23975 1/20 0.32
AHR P35869 1/20 0.32
CYP2C9 P11712 2/20 0.32
HPGD P15428 2/20 0.32
CYP2C19 P33261 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HSD17B1 P14061 2/20 0.32
HSD17B2 P37059 2/20 0.32
CYP2A6 P11509 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2989232 0.89 CYP1A2 (0.37) CYP1A2ALDH1A1MAPTLCKFYN
SCHEMBL13775279 0.85 TNKS2 (0.37) ALDH1A1MAPTNPC1
SCHEMBL1376567 0.83 CYP1A2 (0.38) CYP1A2ALDH1A1MAPTACHENPSR1
SCHEMBL13775184 0.81 HTT (0.34) CYP1A2ALDH1A1HPGDNPSR1CYP2A6
SCHEMBL13775185 0.81 KIF11 (0.33) CYP1A2ALDH1A1MAPTHPGDNPSR1
SCHEMBL22246993 0.81 S1PR1 (0.35) CYP1A2
SCHEMBL13775228 0.80 CYP2A6 (0.46) CYP1A2MAPTSLC6A2CYP2C9CYP2C19
SCHEMBL22671287 0.80 ESR1 (0.41) ESR1ESR2ALOX5CYP1A2ALDH1A1
SCHEMBL10122848 0.80 GSTP1 (0.36) ESR1ESR2CYP1A2ALDH1A1SLC6A2
SCHEMBL13775273 0.79 KIF11 (0.34) CYP1A2ALDH1A1MAPTHPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090189522-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDERNITSU KOSAN CO., LTD. (JP) 2009-07-30 US disclosed
US-20090189522-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDERNITSU KOSAN CO., LTD. (JP) 2009-07-30 US disclosed
US-7524568-B2 Aromatic amine derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2009-04-28 US disclosed
US-7524568-B2 Aromatic amine derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2009-04-28 US disclosed
US-20080268283-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-10-30 US disclosed
US-20080268283-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-10-30 US disclosed
US-7425653-B2 Aromatic amine derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2008-09-16 US disclosed
US-7425653-B2 Aromatic amine derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2008-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080268283-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME TYR, MAOA, AOC2 ESR1 240/4885ESR2 456/4885ALOX5 3688/4885
US-20090189522-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME TYR, MAOA, AOC2 ESR1 240/4885ESR2 456/4885ALOX5 3688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.